Form 8.5 (EPT/RI) - Booker Group plc FORM 8.5

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
20
Form 8.5 (EPT/RI) - Booker Group plc

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

1.         KEY INFORMATION

(a) Name of exempt principal trader:   Investec Bank plc  
(b) Name of offeror/offeree in relation to whose relevant securities this form relates:      Use a separate form for each offeror/offeree   Booker Group plc
(c) Name of the party to the offer with which exempt principal trader is connected:     Investec are Broker to Booker Group plc  
(d) Date dealing undertaken:    5th May 2017  
(e) Has the EPT previously disclosed, or is it today disclosing, in respect of any other party to this offer? Yes

2.         DEALINGS BY THE EXEMPT PRINCIPAL TRADER

(a)        Purchases and sales

Class of relevant security Purchases/ sales   Total number of securities Highest price per unit paid/received (pence)   Lowest price per unit paid/received (pence)
  Ordinary Shares   Purchase   750,000   193.95   192.6
  Ordinary Shares   Sales   750,000   194   192.3

(b)        Derivatives transactions (other than options)

Class of relevant security Product description e.g. CFD Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit
           

(c)        Options transactions in respect of existing securities

(i)         Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit
               

(ii)        Exercising

Class of relevant security Product description e.g. call option Number of securities Exercise price per unit
         

(d)        Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable)
         

The currency of all prices and other monetary amounts should be stated.

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

3.         OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: If there are no such agreements, arrangements or understandings, state "none"
  None

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i)  the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none"
  None
  Date of disclosure: 8th May 2017
  Contact name:   Gary Darch
  Telephone number:   0207 597 4549
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Recursion and Exscientia Unite for Groundbreaking Drug Discovery

Updated Category News Views 96

Recursion and Exscientia Join Forces for Advanced Drug Discovery Two trailblazers in the field of AI-driven drug discovery, Recursion and Exscientia, have officially merged to create a robust entity focused on transforming the landscape of drug development. This amalgamation marks a significant milestone in their shared mission to expedite the discovery of innovative...

Continue Reading
Innovative Ergodyne Type 2 Helmets: Style Meets Safety

Updated Category News Views 402

Introducing Ergodyne's Type 2 Safety Helmets Ergodyne has unveiled its latest innovation in safety gear, the new Type 2 Safety Helmets, designed to balance familiar aesthetics with enhanced protection. These helmets aim to ease worker reluctance towards new equipment by merging the classic design of a full brim hard hat with the advanced safety features that Type 2...

Continue Reading
Palantir Technologies: Navigating Market Challenges Ahead

Updated Category News Views 227

Palantir Technologies: An Overview of Current Stock Trends Palantir Technologies (NASDAQ: PLTR) has recently experienced fluctuations in its stock prices, especially after being announced as a new member of the NASDAQ 100. In the days following this announcement, investors observed a pullback of more than 5%, which can be closely tied to broader market trends influenced...

Continue Reading
Citi Downgrades Woodside Stock Due to Persisting Investor Worries

Updated Category News Views 75

Citi dropped a bomb on Woodside Energy Group back when they revised their outlook, cutting the price target from AUD 24.50 to AUD 23.00 while keeping that pesky Sell rating in play. Why? Well, investor nerves around dividends and looming corporate mergers were in the air like a bad hangover at the trading desk. Citi’s Reckoning: EPS Boost or Dividend Squeeze? The update...

Continue Reading
Lantheus Holdings Faces Class Action Lawsuit: Key Details Inside

Updated Category News Views 127

Understanding the Class Action Lawsuit Against Lantheus Holdings, Inc. Investors in Lantheus Holdings, Inc. (NASDAQ: LNTH) should be aware of a class action lawsuit that has been initiated, which could represent a significant opportunity for those who believe they've suffered losses due to the company's actions. This notable legal action is spearheaded by the reputable...

Continue Reading